USPTO Deadlines
Next Deadline
889 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-01-11)
Due Date
January 11, 2028
Grace Period Ends
July 11, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
16 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jan 11, 2022 | R.SR | A | REGISTERED-SUPPLEMENTAL REGISTER | Loading... |
Dec 7, 2021 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Dec 3, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
Dec 2, 2021 | CNTA | O | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | Loading... |
Nov 5, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Nov 5, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Nov 5, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Nov 5, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Sep 22, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Sep 22, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Sep 22, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Mar 27, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Mar 27, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Mar 27, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Mar 20, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Dec 8, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 035
Consulting services in the cost management of health care benefit plans for others, namely, identifying and eliminating prescription drug waste through targeting older drugs marketed as newer drugs, drugs with new formulations, and drugs with specific dosages
First Use Anywhere:
Dec 15, 2016
First Use in Commerce:
Dec 15, 2016
Classification
International Classes
035
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"FORMULARY"